Highlander Capital Management’s Zosano Pharma Corporation ZSAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-600
| Closed | – | – | 663 |
|
|
2022
Q3 | $0 | Hold |
600
| – | – | ﹤0.01% | 654 |
|
|
2022
Q2 | $0 | Hold |
600
| – | – | ﹤0.01% | 662 |
|
|
2022
Q1 | $5K | Hold |
600
| – | – | ﹤0.01% | 541 |
|
|
2021
Q4 | $10K | Sell |
600
-286
| -32% | -$6.04K | ﹤0.01% | 472 |
|
|
2021
Q3 | $22K | Hold |
886
| – | – | 0.01% | 389 |
|
|
2021
Q2 | $29K | Buy |
886
+600
| +210% | +$19.3K | 0.01% | 366 |
|
|
2021
Q1 | $12K | Hold |
286
| – | – | 0.01% | 467 |
|
|
2020
Q4 | $5K | Hold |
286
| – | – | ﹤0.01% | 539 |
|
|
2020
Q3 | $16K | Hold |
286
| – | – | 0.01% | 435 |
|
|
2020
Q2 | $9K | Hold |
286
| – | – | 0.01% | 496 |
|
|
2020
Q1 | $6K | Hold |
286
| – | – | ﹤0.01% | 535 |
|
|
2019
Q4 | $15K | Hold |
286
| – | – | 0.01% | 466 |
|
|
2019
Q3 | $16K | Hold |
286
| – | – | 0.01% | 465 |
|
|
2019
Q2 | $33K | Hold |
286
| – | – | 0.02% | 380 |
|
|
2019
Q1 | $48K | Hold |
286
| – | – | 0.03% | 329 |
|
|
2018
Q4 | $21K | Hold |
286
| – | – | 0.01% | 435 |
|
|
2018
Q3 | $41K | Hold |
286
| – | – | 0.02% | 380 |
|
|
2018
Q2 | $41K | Hold |
286
| – | – | 0.02% | 383 |
|
|
2018
Q1 | $50K | Hold |
286
| – | – | 0.03% | 356 |
|
|
2017
Q4 | $104K | Buy |
+286
| New | +$144K | 0.08% | 249 |
|
Highlander Capital Management's ZSAN Position: Q4 2022 in Review
Highlander Capital Management sold out of Zosano Pharma Corporation (ZSAN) in Q4 2022, closing a stake of 600 shares.
Highlander Capital Management first reported a position in ZSAN in Q4 2017 and held it in 20 quarters. The position peaked at $104K in Q4 2017. 0 funds tracked by Wall St. Rank hold ZSAN as of Q4 2022.
- Highlander Capital Management reported no remaining Zosano Pharma Corporation position as of Q4 2022 after selling out during the quarter.
- Highlander Capital Management sold 600 Zosano Pharma Corporation shares in Q4 2022.
- Highlander Capital Management first reported a position in Zosano Pharma Corporation in Q4 2017 and held it in 20 quarters.
- Highlander Capital Management's Zosano Pharma Corporation position peaked at $104K in Q4 2017.
- 0 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q4 2022.
Based on Highlander Capital Management's 13F filing for Q4 2022, filed 15 Feb 2023.